R. Erik Holmlin - 15 Feb 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
15 Feb 2025
Transactions value $
-$292
Form type
4
Date filed
19 Feb 2025, 18:56
Previous filing
05 Jun 2024
Next filing
18 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability -$292 -51 -2.51% $5.73 1.98K 15 Feb 2025 Direct F1, F2, F3
holding BNGO Common Stock 8 15 Feb 2025 Robert Erik Holmlin Traditional IRA F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
F2 On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 120,428 less shares of common stock (119,934 less shares held directly and 494 less shares held indirectly).
F3 Includes 2 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024 (As adjusted for the January 2025 Reverse Stock Split).